Literature DB >> 9687009

Nociceptin receptor-mediated Ca2+ channel inhibition and its desensitization in NG108-15 cells.

H Morikawa1, K Fukuda, H Mima, T Shoda, S Kato, K Mori.   

Abstract

It has been shown that the membrane of hybrid NG108-15 neuroblastoma x glioma cells contains a high-affinity binding site for nociceptin. In the present study, we first demonstrated the expression of nociceptin receptor mRNA in NG108-15 cells. Application of nociceptin to NG108-15 cells produced a concentration-dependent (EC50 = 29 nM) inhibition of Ca2+ channel currents in a pertussis toxin-sensitive fashion. This nociceptin-induced inhibition of Ca2+ channel currents was prevented in the presence of omega-conotoxin GVIA, a blocker of the N-type Ca2+ channel, and had both voltage-dependent and -independent components. Prolonged application of nociceptin elicited homologous desensitization of the inhibition with a time constant of 5.3 min. These results indicate that the nociceptin receptor is coupled to the N-type Ca2+ channel via pertussis toxin-sensitive G proteins in NG108-15 cells and that this coupling is associated with rapid and homologous desensitization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687009     DOI: 10.1016/s0014-2999(98)00306-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal.

Authors:  R R Mirotznik; X Zheng; E F Stanley
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Melanin-concentrating hormone depresses L-, N-, and P/Q-type voltage-dependent calcium channels in rat lateral hypothalamic neurons.

Authors:  Xiao-Bing Gao; Anthony N van den Pol
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

3.  Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.

Authors:  A Siniscalchi; D Rodi; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.

Authors:  S Werthwein; U Bauer; M Nakazi; M Kathmann; E Schlicker
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

6.  Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system.

Authors:  T A Barnes; J McDonald; D J Rowbotham; T L Duarte; D G Lambert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-25       Impact factor: 3.000

Review 7.  Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

Authors:  Courtney L Donica; Hibah O Awwad; Deepak R Thakker; Kelly M Standifer
Journal:  Mol Pharmacol       Date:  2013-02-08       Impact factor: 4.436

Review 8.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 9.  CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics.

Authors:  Paul J Buchanan; Karen D McCloskey
Journal:  Eur Biophys J       Date:  2016-06-24       Impact factor: 1.733

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.